Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ephedrine

This article was originally published in The Tan Sheet

Executive Summary

Safety of the stimulant ingredient was discussed at a meeting the week of May 30 between FDA and representatives from CRN, NDMA, NNFA, American Herbal Products Association and Utah Natural Products Alliance. NNFA has recommended a voluntary warning label developed by AHPA on ephedrine-containing products. Also discussed were tryptophan, germanium and comfrey products. Ephedrine was the subject of a June 7 "Dateline NBC" segment focusing on two teen- agers hospitalized in Texas and one teen death in Ohio following ingestion of large amounts of ephedrine. Texas has since prohibited ephedrine sales to persons younger than 18 and banned a product called Formula One
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel